Johann-Caspar Gammelin, currently Chairman of the Board of Management of Evonik Performance Materials GmbH, will take over as Chairman of the Board of Management of Evonik Nutrition and Care GmbH from Dr. Reiner Beste, effective April 1, 2019.
On this date Dr. Beste, as new Regional President, will assume responsibility for bringing together the two regions Asia Pacific North and Asia Pacific South. “The attractive growth markets in Asia are of special importance to Evonik”, says Christian Kullmann, Chairman of the Executive Board of Evonik. “With Reiner Beste, our aim is to strengthen the growth of our numerous businesses there.”
The successor to Mr. Gammelin as Chairman of the Board of Management of Evonik Performance Materials GmbH will be Dr. Joachim Dahm.
Together with Mr. Gammelin and Dr. Dahm, in future, Dr. Claus Rettig, as Chairman of Evonik Resource Efficiency GmbH, and Gregor Hetzke, as Chairman of Evonik Technology and Infrastructure GmbH, will participate in the meetings of the Executive Board.
Dr. Rainer Fretzen will join the Board of Management of Evonik Technology and Infrastructure, taking over the position of Chairman from Gregor Hetzke on September 1, 2019. From that time on, Dr. Fretzen will therefore participate in Executive Board meetings.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.